Chongqing Sansheng Industrial Co.,Ltd.

Shenzhen Stock Exchange 002742.SZ

Chongqing Sansheng Industrial Co.,Ltd. Price to Earnings Ratio (P/E) on January 27, 2025: -3.55

Chongqing Sansheng Industrial Co.,Ltd. Price to Earnings Ratio (P/E) is -3.55 on January 27, 2025, a -10.36% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Chongqing Sansheng Industrial Co.,Ltd. 52-week high Price to Earnings Ratio (P/E) is -1.18 on June 06, 2024, which is 66.82% above the current Price to Earnings Ratio (P/E).
  • Chongqing Sansheng Industrial Co.,Ltd. 52-week low Price to Earnings Ratio (P/E) is -4.74 on November 14, 2024, which is -33.33% below the current Price to Earnings Ratio (P/E).
  • Chongqing Sansheng Industrial Co.,Ltd. average Price to Earnings Ratio (P/E) for the last 52 weeks is -2.79.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 002742.SZ

Chongqing Sansheng Industrial Co.,Ltd.

CEO Mr. Zhi Qiang Zhang
IPO Date Feb. 17, 2015
Location China
Headquarters No.1 Yunhan Road
Employees 2,039
Sector Materials
Industries
Description

Chongqing Sansheng Industrial Co.,Ltd. engages in the research and development, production, and sale of building materials and chemicals in China. The company offers commercial concrete, water reducing agents, and expansion agents for industrial and civil buildings, highways, railways, bridges, tunnels, airports, water conservancy and hydropower, etc.; and sulfuric acid for the production of chemical fertilizers, chemical, light industry, textile, steel, water reducer, and other non-fertilizer acid enterprises. It also provides pharmaceutical products comprising intermediates, such as procaine hydrochloride, cefoxitin intermediate, chloramphenicol intermediate, aztreonam intermediate, orlistat intermediate, etc., which are used in antibiotic drugs, anti-hepatitis C drugs, diabetes medicines, benzathine penicillin and cefoxitin, procaine penicillin, and cosmetics; API products, including acetaminophen, cloperidine hydrochloride, levofloxacin mesylate, benoate, procaine hydrochloride, diphenhydramine hydrochloride, etc.; and preparation products, such as compound paracetamol diphenhydramine, cloperidine hydrochloride, clarithromycin sustained-release, diclofenac sodium enteric-coated, acetaminophen, famotidine tablets, etc., which are used in antipyretic and analgesic, antiviral, antibacterial, cough, allergy, local anesthesia, etc., as well as famotidine, diclofenac sodium, nifedipine, acetaminophen, furosemide, and norfloxacin drugs for clinical needs. The company was formerly known as Chongqing Sansheng Special Building Materials Co., Ltd. and changed its name to Chongqing Sansheng Industrial Co.,Ltd. in October 2016. The company was founded in 2002 and is based in Chongqing, China.

Similar companies

002785.SZ

Xiamen Wanli Stone Stock Co.,Ltd

USD 4.41

NA

002669.SZ

Kangda New Materials (Group) Co., Ltd.

USD 1.31

NA

002641.SZ

Era Co., Ltd.

USD 0.58

NA

002741.SZ

Guangdong Guanghua Sci-Tech Co., Ltd.

USD 2.12

NA

StockViz Staff

February 1, 2025

Any question? Send us an email